| |
 |
SPECIAL ARTICLES
|
|
| Cancer Treatment in the STI571 Era: What Will Change? |
| Charles L. Sawyers |
|
JCO Sep 15 2001: 13s–16s.
[Full Text]
[PDF]
|
 |
| Plenary Debate of Randomized Phase III Trial of Neoadjuvant MVAC Plus Cystectomy Versus Cystectomy Alone in Patients With Locally Advanced Bladder Cancer |
| Dean F. Bajorin |
|
JCO Sep 15 2001: 17s–20s.
[Full Text]
[PDF]
|
 |
| Neoadjuvant Chemotherapy Is Not (Yet) Standard Treatment for Muscle-Invasive Bladder Cancer |
| Cora N. Sternberg and Mahesh K.B. Parmar |
|
JCO Sep 15 2001: 21s–26s.
[Full Text]
[PDF]
|
 |
| Commentary: Phase III Trial to Preserve the Larynx: Induction Chemotherapy and Radiotherapy Versus Concurrent Chemotherapy and Radiotherapy Versus RadiotherapyIntergroup Trial R91-11 |
| Gregory T. Wolf |
|
JCO Sep 15 2001: 28s–31s.
[Full Text]
[PDF]
|
 |
|
The Epidermal Growth Factor Receptor: From Mutant Oncogene in Nonhuman Cancers to Therapeutic Target in Human Neoplasia |
| |
Carlos L. Arteaga |
| |
JCO Sep 15 2001: 32s–40s.
[Abstract]
[Full Text]
[PDF]
|
 |
| Targeting the Epidermal Growth Factor Receptor: A Clinical Reality |
| José Baselga |
|
JCO Sep 15 2001: 41s–44s.
[Full Text]
[PDF]
|
 |
| Clinical Trials of Antiangiogenic Drugs: Opportunities, Problems, and Assessment of Initial Results |
| Robert S. Kerbel |
|
JCO Sep 15 2001: 45s–51s.
[Full Text]
[PDF]
|
 |
| Interactions Between Academic Oncology and Alternative/Complementary/Integrative Medicine: Complex But Necessary |
| Maurie Markman |
|
JCO Sep 15 2001: 52s–53s.
[Full Text]
[PDF]
|
 |
| Overview |
| David S. Rosenthal and Maurie Markman |
|
JCO Sep 15 2001: 54s.
[Full Text]
[PDF]
|
 |
| Complementary and Alternative Medicine: The Role of the Cancer Center |
| Karen Antman, Mitchell C. Benson, John Chabot, David Cobrinik, Victor R. Grann, Judith S. Jacobson, Andrew K. Joe, Aaron E. Katz, Kara Kelly, Alfred I. Neugut, Donna Russo, Amy Tiersten, and I. Bernard Weinstein |
|
JCO Sep 15 2001: 55s–60s.
[Full Text]
[PDF]
|
 |
| Enhancing Doctor-Patient Communication |
| Barrie R. Cassileth |
|
JCO Sep 15 2001: 61s–63s.
[Full Text]
[PDF]
|
 |